Archive for February, 2018

23
Feb

Merck Bids $1.75 for Viralytics

Merck Bids $1.75 for Viralytics

Merck (NYSE:MRK) and Viralytics announced overnight the agreed acquisition of Viralytics by Merck for A$1.75 cash. The stock last traded at 63 cents prior to the announcement. VLA hit a high of $1.26 in December 2016.

22
Feb

QUEST AGAIN A LONSEC FINALIST

QUEST AGAIN A LONSEC FINALIST

Quest Asset Partners are a finalist in the Lonsec Fund Manager Awards for the second year in a row.